Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
2018 · Nature Medicine · 5,444 citations
https://doi.org/10.1038/s41591-018-0136-1
D
Deng Pan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
228
Papers
9.5K
Citations
30
h-index
55
i10-index
Deng Pan is an academic researcher from Beijing Tongren Hospital. The author has contributed to research in topics: CAR-T cell therapy research & Cancer Immunotherapy and Biomarkers & Immune cells in cancer. The author has an h-index of 30, co-authored 194 publications.
ORCID: 0000-0002-6475-0463Papers by this author
worksCOCO enhances the efficiency of photoreceptor precursor differentiation in early human embryonic stem cell-derived retinal organoids
2020 · Stem Cell Research & Therapy · 111 citations
https://doi.org/10.1186/s13287-020-01883-5
Decreased Expression of Hepatocyte Nuclear Factor 4α (Hnf4α)/MicroRNA-122 (miR-122) Axis in Hepatitis B Virus-associated Hepatocellular Carcinoma Enhances Potential Oncogenic GALNT10 Protein Activity
2014 · Journal of Biological Chemistry · 93 citations
https://doi.org/10.1074/jbc.m114.601203
Tumor-derived Jagged1 promotes cancer progression through immune evasion
2022 · Cell Reports · 45 citations
https://doi.org/10.1016/j.celrep.2022.110492
The CBM Complex Underwrites NF-κB Activation to Promote HER2-Associated Tumor Malignancy
2015 · Molecular Cancer Research · 36 citations
https://doi.org/10.1158/1541-7786.mcr-15-0229-t
Potentiating anti-tumor immunity by re-engaging immune synapse molecules
2025 · Cell Reports Medicine · 15 citations
https://doi.org/10.1016/j.xcrm.2025.101975
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat